Athersys Receives IND Authorization for Multistem in Treatment of Ischemic Stroke Athersys Receives IND Authorization for Multistem in Treatment of Ischemic Stroke
NicOx’ Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis NicOx’ Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis
Neurobiological Technologies Announces Viprinex Does Not Pass Interim Futility Analysis Neurobiological Technologies Announces Viprinex Does Not Pass Interim Futility Analysis
DIAS-2 results leave desmoteplase benefits uncertain DIAS-2 results leave desmoteplase benefits uncertain
Elevated D-dimer found in African-American hypertension patients Elevated D-dimer found in African-American hypertension patients
CHHIPS published: BP control may reduce stroke mortality CHHIPS published: BP control may reduce stroke mortality
Intensive nutritional supplements can improve outcomes in stroke rehabilitation Intensive nutritional supplements can improve outcomes in stroke rehabilitation
Dose management strategy key to improving warfarin benefits Dose management strategy key to improving warfarin benefits
Get With the Guidelines?Stroke Is Associated With Sustained Improvement in Care for Patients Hospitalized With Acute Stroke or Transient Ischemic Attack Get With the Guidelines?Stroke Is Associated With Sustained Improvement in Care for Patients Hospitalized With Acute Stroke or Transient Ischemic Attack
Death rates for heart disease and stroke drop significantly Death rates for heart disease and stroke drop significantly
Treadmill Exercise is Important for Stroke Rehabilitation Treadmill Exercise is Important for Stroke Rehabilitation
Novel bedside tool identifies dysphagia in stroke patients Novel bedside tool identifies dysphagia in stroke patients
TGF release predicts chronic communicating hydrocephalus after SAH TGF release predicts chronic communicating hydrocephalus after SAH
Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation
Two-drug BP therapy can prevent heart attack, stroke Two-drug BP therapy can prevent heart attack, stroke
Substantial disability persists in two-thirds of stroke survivors Substantial disability persists in two-thirds of stroke survivors
Takotsubo cardiomyopathy can complicate ischemic stroke Takotsubo cardiomyopathy can complicate ischemic stroke
